Analysen von Trung Huynh

20.01.21 Merck Outperform Credit Suisse Group
20.01.21 Bayer Neutral Credit Suisse Group
20.01.21 Sanofi Outperform Credit Suisse Group
20.01.21 AstraZeneca Outperform Credit Suisse Group
20.01.21 Novartis Neutral Credit Suisse Group
20.01.21 Roche Neutral Credit Suisse Group
20.01.21 Novo Nordisk Neutral Credit Suisse Group
20.01.21 GSK Underperform Credit Suisse Group
04.11.20 Bayer Neutral Credit Suisse Group
02.11.20 Novo Nordisk Outperform Credit Suisse Group
30.10.20 Bayer Neutral Credit Suisse Group
30.10.20 Sanofi Outperform Credit Suisse Group
29.10.20 GSK Neutral Credit Suisse Group
28.10.20 Novartis Neutral Credit Suisse Group
23.10.20 GSK Neutral Credit Suisse Group
12.10.20 Novo Nordisk Outperform Credit Suisse Group
05.10.20 GSK Neutral Credit Suisse Group
17.09.20 Merck Outperform Credit Suisse Group
03.09.20 Bayer Neutral Credit Suisse Group
18.08.20 Sanofi Outperform Credit Suisse Group
10.08.20 Novo Nordisk Outperform Credit Suisse Group
07.08.20 Novo Nordisk Outperform Credit Suisse Group
07.08.20 Merck Outperform Credit Suisse Group
03.08.20 Sanofi Outperform Credit Suisse Group
31.07.20 AstraZeneca Outperform Credit Suisse Group
30.07.20 Sanofi Outperform Credit Suisse Group
30.07.20 GSK Neutral Credit Suisse Group
29.07.20 Roche Neutral Credit Suisse Group
28.07.20 AstraZeneca Outperform Credit Suisse Group
23.07.20 Merck Outperform Credit Suisse Group
22.07.20 Merck Outperform Credit Suisse Group
22.07.20 Novartis Neutral Credit Suisse Group
25.06.20 Roche Neutral Credit Suisse Group
12.06.20 Sanofi Outperform Credit Suisse Group
08.06.20 AstraZeneca Outperform Credit Suisse Group
03.06.20 Sanofi Outperform Credit Suisse Group
07.05.20 Novo Nordisk Outperform Credit Suisse Group
05.05.20 Merck Outperform Credit Suisse Group
30.04.20 GSK Neutral Credit Suisse Group
30.04.20 AstraZeneca Outperform Credit Suisse Group
29.04.20 Novartis Neutral Credit Suisse Group
27.04.20 Sanofi Outperform Credit Suisse Group
20.02.20 Merck Outperform Credit Suisse Group
07.02.20 Sanofi Outperform Credit Suisse Group
06.02.20 Novo Nordisk Outperform Credit Suisse Group
06.02.20 GSK Neutral Credit Suisse Group
31.01.20 Roche Neutral Credit Suisse Group
30.01.20 Novartis Neutral Credit Suisse Group
16.01.20 Novo Nordisk Outperform Credit Suisse Group
16.01.20 Roche Neutral Credit Suisse Group